Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Insulin lispro biphasic 25/75 100units/ml inj 3ml cartridges
0601012F0AAABAB
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | 11 |
|
Insulin lispro biphasic 50/50 100units/ml inj 3ml cartridges
0601012F0AAADAD
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | 1 |
|
Insulin lispro biphasic 25/75 100u/ml inj 3ml pf dispos dev
0601012F0AAAAAA
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | No data available |
|
Insulin lispro biphasic 25/75 100units/ml inj 10ml vials
0601012F0AAAEAE
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | No data available |
|
Insulin lispro biphasic 50/50 100u/ml inj 3ml pf dispos dev
0601012F0AAACAC
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.